Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 97
Filtrar
1.
Parasitology ; 143(13): 1713-1722, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27609526

RESUMO

Blastocystis spp. pathogenic potential remains unclear as these anaerobic parasitic protozoa are frequently isolated from stools of both symptomatic and asymptomatic subjects. In silico analysis of the whole genome sequence of Blastocystis subtype 7 revealed the presence of numerous proteolytic enzymes including cysteine proteases predicted to be secreted. To assess the potential impact of proteases on intestinal cells and gut function, we focused our study on two cysteine proteases, a legumain and a cathepsin B, which were previously identified in Blastocystis subtype 7 culture supernatants. Both cysteine proteases were produced as active recombinant proteins. Activation of the recombinant legumain was shown to be autocatalytic and triggered by acidic pH, whereas proteolytic activity of the recombinant cathepsin B was only recorded after co-incubation with the legumain. We then measured the diffusion of 4-kDa FITC-labelled dextran across Caco-2 cell monolayers following exposition to either Blastocystis culture supernatants or each recombinant protease. Both Blastocystis culture supernatants and recombinant activated cathepsin B induced an increase of Caco-2 cell monolayer permeability, and this effect was significantly inhibited by E-64, a specific cysteine protease inhibitor. Our results suggest that cathepsin B might play a role in pathogenesis of Blastocystis by increasing intestinal cell permeability.


Assuntos
Blastocystis/enzimologia , Catepsina B/metabolismo , Cisteína Endopeptidases/metabolismo , Células Epiteliais/fisiologia , Permeabilidade/efeitos dos fármacos , Células CACO-2 , Catepsina B/genética , Cisteína Endopeptidases/genética , Células Epiteliais/efeitos dos fármacos , Humanos , Processamento de Proteína Pós-Traducional , Proteólise , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo
2.
Int J Obes (Lond) ; 39(11): 1638-43, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26095245

RESUMO

BACKGROUND/OBJECTIVES: Although weight loss has been associated with changes in circulating 25-hydroxyvitamin D (25(OH)D) levels, the quantification of the increase in 25(OH)D levels as a function of adipose tissue volume loss precisely assessed by imaging has not been reported before. The objective of this substudy was to describe the effects of a 1-year lifestyle intervention on plasma 25(OH)D levels. The relationships between changes in 25(OH)D levels and changes in adiposity volume (total and by adipose tissue compartment) were studied. SUBJECTS/METHODS: This intervention study was performed between 2004 and 2006 and participants were recruited from the general community. Sedentary, abdominally obese and dyslipidemic men (n=103) were involved in a 1-year lifestyle modification program. Subjects were individually counseled by a kinesiologist and a nutritionist once every 2 weeks during the first 4 months with subsequent monthly visits in order to elicit a 500-kcal daily energy deficit and to increase physical activity/exercise habits. Body weight, body composition and fat distribution were assessed by dual-energy X-ray absorptiometry and computed tomography, whereas the 25(OH)D levels were measured with an automated assay. RESULTS: The 1-year intervention resulted in a 26% increase in circulating 25(OH)D (from 48±2 nmol l(-1) or 19±0.8 ng ml(-1) (±s.e.m.) to 58±2 nmol l(-1) or 23±0.8 ng ml(-1), P<0.0001) along with a 26% decrease in visceral adiposity volume (from 1947±458 to 1459±532 cm3). One-year increases in 25(OH)D levels correlated inversely with changes in all adiposity indices, especially Δvisceral (r=-0.36, P<0.0005) and Δtotal abdominal (r=-0.37, P<0.0005) adipose tissue volumes. CONCLUSIONS: These results indicate that there is a linear increase in circulating 25(OH)D levels as a function of adiposity volume loss, and therefore suggest a role of adiposity reduction in the management of obesity-associated vitamin D insufficiency.


Assuntos
Restrição Calórica , Dislipidemias/sangue , Exercício Físico , Obesidade/sangue , Comportamento de Redução do Risco , Vitamina D/análogos & derivados , Redução de Peso , Tecido Adiposo , Adiposidade , Adulto , Biomarcadores/sangue , Dislipidemias/terapia , Comportamento Alimentar , Humanos , Masculino , Saúde do Homem , Pessoa de Meia-Idade , Obesidade/complicações , Obesidade/prevenção & controle , Quebeque , Valores de Referência , Resultado do Tratamento , Vitamina D/sangue
3.
Int J Clin Pract ; 69(3): 305-12, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25359240

RESUMO

AIMS: Although many elderly individuals suffer from type 2 diabetes, the effectiveness of cardioprotective drugs in primary prevention of cardiovascular events in clinical practice in this population has rarely been evaluated. We aimed to assess the effectiveness of, (i) angiotensin converting enzyme inhibitors or angiotensin receptor blockers, (ii) statins, (iii) antiplatelet drugs and (iv) the combination of these three drugs, in the prevention of myocardial infarction (MI) and stroke in elderly individuals with type 2 diabetes. METHODS: Using Quebec administrative databases, we conducted nested case-control analyses among a cohort of 17,384 individuals without a history of cardiovascular disease. Individuals were aged ≥ 66 years, newly treated with oral antidiabetes drugs and had not used any of the three above classes of cardioprotective drugs in the year before cohort entry. For each case (MI/stroke during follow-up), five controls were matched for age, year of cohort entry and sex. Use of each drug and of their combination was defined as current, past or no use. We calculated adjusted odds ratios (AOR) of MI/stroke. RESULTS: We observed no reduction in the MI/stroke risk for users of ACEI/ARB nor for users of the three drugs combination. Longer exposure to statins was associated with a lower risk (AOR for every 30 days of therapy: 0.97; 95% CI: 0.96-0.99). By contrast, current use of antiplatelet drugs was associated with an increased risk of MI/stroke (1.40; 1.12-1.75). CONCLUSION: The benefit of cardioprotective drugs in primary prevention was not clear in this cohort of elderly individuals with type 2 diabetes. A short duration of exposure to these drugs might explain the lack of benefit.


Assuntos
Fármacos Cardiovasculares/uso terapêutico , Doenças Cardiovasculares/prevenção & controle , Diabetes Mellitus Tipo 2/complicações , Prevenção Primária/métodos , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/etiologia , Diabetes Mellitus Tipo 2/tratamento farmacológico , Feminino , Seguimentos , Humanos , Incidência , Masculino , Prognóstico , Quebeque/epidemiologia , Estudos Retrospectivos , Fatores de Risco
4.
Int Arch Occup Environ Health ; 88(7): 973-80, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25655920

RESUMO

PURPOSE: Occupational stress and obesity are very prevalent in emergency workers. Some studies have also associated high tobacco consumption rates with occupational stress. Each of these factors is known to increase cardiovascular risk. The aim of this study was to evaluate the prevalence of occupational stress, overweight and tobacco consumption in paramedics. METHODS: This cross-sectional study of paramedics consisted in a self-report survey of 44 questions divided into two sections. The first section collected demographic information and the second evaluated occupational stressors. The questions were designed to determine the prevalence of work-related psychosocial factors, overweight (body mass index ≥ 25 kg/m(2)) and tobacco consumption (cig/day ≥ 1). The demand-control-social support model and the effort-reward model were used to estimate job strain, iso-strain and imbalance in effort and reward. RESULTS: More than 88 % of paramedics reported at least one cardiovascular risk factor, with males reporting more risk factors than females. Ninety percent of male paramedics reported occupational stress, 12 % reported smoking, and 79 % were overweight or obese by self-report. The prevalence of occupational stress and smoking was similar for female paramedics, but with a lower prevalence of overweight (37 %). CONCLUSION: By self-report, nine out of ten paramedics are at risk of developing cardiovascular disease. Both individual and organizational efforts should be made to educate and support paramedics and their organizations in reducing these workers' cardiovascular risk.


Assuntos
Pessoal Técnico de Saúde/estatística & dados numéricos , Doenças Cardiovasculares/etiologia , Obesidade/epidemiologia , Doenças Profissionais/etiologia , Estresse Psicológico/epidemiologia , Adulto , Estudos Transversais , Feminino , Humanos , Masculino , Obesidade/complicações , Doenças Profissionais/epidemiologia , Prevalência , Fatores de Risco , Autorrelato , Distribuição por Sexo , Fumar/efeitos adversos , Estresse Psicológico/complicações
5.
Parasitology ; 141(5): 670-81, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24467909

RESUMO

Blastocystis spp. are common anaerobic intestinal protozoa found in both human and animals. They are characterized by a high genetic diversity with at least 17 subtypes (STs) that have been described on the basis of a 600 bp 'barcoding region' from the 18S rDNA gene. However, analysis of the recently sequenced genome of a Blastocystis ST7 isolate (strain B) revealed the presence of multiple variable copies of the 18S rDNA gene, with 17 completely assembled copies. Comparison of the barcoding region from these 17 copies allowed us to classify the 18S rDNA sequences into 6 clusters, each cluster containing identical sequences. Surprisingly, 4 of these clusters had the highest homology with 18S rDNA sequences from 2 other Blastocystis ST7 isolates referred as QQ98-4 and H. These results suggest that the 18S rDNA gene is not the marker of choice to discriminate between strains within STs. In the present study, we identified a single-copy subtyping rDNA marker in the genome of the mitochondria-like organelles (MLOs). Using a partial sequence of the MLO rDNA, we successfully subtyped 66 isolates from both human and animals belonging to Blastocystis ST1 to ST10. Our results also indicate that this mitochondrial marker could be useful to detect co-infections by different isolates of a same ST.


Assuntos
Infecções por Blastocystis/parasitologia , Blastocystis/classificação , Genoma de Protozoário/genética , Polimorfismo Genético , Animais , Sequência de Bases , Blastocystis/genética , Blastocystis/isolamento & purificação , Coinfecção , Código de Barras de DNA Taxonômico , DNA de Protozoário/química , DNA de Protozoário/genética , DNA Ribossômico/química , DNA Ribossômico/genética , Marcadores Genéticos/genética , Genótipo , Humanos , Mitocôndrias/genética , Dados de Sequência Molecular , Tipagem Molecular , Organelas/genética , Filogenia , RNA Ribossômico 18S/genética , Alinhamento de Sequência , Análise de Sequência de DNA
6.
Diabetes Obes Metab ; 15(12): 1093-100, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23683111

RESUMO

AIM: To investigate the cardiometabolic risk (CMR) assessment and management patterns for individuals with and without type 2 diabetes mellitus (T2DM) in Canadian primary care practices. METHODS: Between April 2011 and March 2012, physicians from 9 primary care teams and 88 traditional non-team practices completed a practice assessment on the management of 2461 patients >40 years old with no clinical evidence of cardiovascular disease and diagnosed with at least one of the following risk factor-T2DM, dyslipidaemia or hypertension. RESULTS: There were 1304 individuals with T2DM and 1157 without. Pharmacotherapy to manage hyperglycaemia, dyslipidaemia and hypertension was widely prescribed. Fifty-eight percent of individuals with T2DM had a glycated haemoglobin (HbA1c) ≤7.0%. Amongst individuals with dyslipidaemia, median low-density lipoprotein cholesterol (LDL-C) was 1.8 mmol/l for those with T2DM and 2.8 mmol/l for those without. Amongst individuals with hypertension, 30% of those with T2DM achieved the <130/80 mmHg target, whereas 60% of those without met the <140/90 mmHg target. The composite glycaemic, LDL-C and blood pressure (BP) target outcome was achieved by 12% of individuals with T2DM. Only 17% of individuals with T2DM and 11% without were advised to increase their physical activity. Dietary modifications were recommended to 32 and 10% of those with and without T2DM, respectively. CONCLUSIONS: Patients at elevated CMR were suboptimally managed in the primary care practices surveyed. There was low attainment of recommended therapeutic glycaemic, lipid and BP targets. Advice on healthy lifestyle changes was infrequently dispensed, representing a missed opportunity to educate patients on the long-term benefits of lifestyle modification.


Assuntos
Diabetes Mellitus Tipo 2/complicações , Dislipidemias/tratamento farmacológico , Hiperglicemia/tratamento farmacológico , Hipertensão/tratamento farmacológico , Adulto , Idoso , Anti-Hipertensivos/uso terapêutico , Colúmbia Britânica , Diabetes Mellitus Tipo 2/tratamento farmacológico , Dislipidemias/complicações , Terapia por Exercício/estatística & dados numéricos , Feminino , Humanos , Hiperglicemia/complicações , Hipertensão/complicações , Hipoglicemiantes/uso terapêutico , Hipolipemiantes/uso terapêutico , Masculino , Pessoa de Meia-Idade , Ontário , Atenção Primária à Saúde/estatística & dados numéricos , Quebeque , Comportamento de Redução do Risco
7.
Eur J Sport Sci ; 23(3): 415-422, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34890532

RESUMO

PURPOSE: To assess the impact of bariatric surgery and an added supervised exercise training programme on heart rate variability (HRV) in patients with severe obesity. METHODS: Fifty-nine patients who underwent bariatric surgery were randomised in the post-operative period to a 12-week supervised exercise training programme (moderate intensity combination aerobic/resistance exercise training programme) or a control group. Indices of HRV including time-domain, spectral-domain, and nonlinear parameters were measured preoperatively, and at 3, 6, and 12 months. RESULTS: After the surgical procedure, both groups improved anthropometric parameters. Type 2 diabetes, hypertension, and dyslipidemia resolutions were similar between groups. Total body weight loss at 6 and 12 months were also comparable between groups (6 months: 28 ± 6 vs. 30 ± 6%; 12 months: 38 ± 9 vs. 38 ± 10%; control vs. intervention group respectively). Bariatric surgery improved HRV parameters at 12 months compared to the pre-operative values in the intervention group: standard deviation of R-R interval (SDNN) (156.0 ± 46.4 vs. 122.6 ± 33.1 ms), low frequency (LF) (6.3 ± 0.8 vs. 5.8 ± 0.7 ms2), and high frequency (HF) (5.1 ± 0.8 vs. 4.7 ± 0.9 ms2) (all p<0.001). For the control patients, similar improvements in SDNN (150.0 ± 39.4 vs. 118.8 ± 20.1 ms), LF (6.1 ± 0.9 vs. 5.7 ± 0.8 ms2), and HF (5.0 ± 0.9 vs. 4.7 ± 0.9 ms2) were obtained (all p<0.001). However, there was no add-on impact of the supervised exercise training programme on HRV after 12 months (p>0.05 for all HRV parameters). CONCLUSION: Bariatric surgery is associated with an improvement in HRV. A supervised exercise training programme in the post-operative period did not modulate further the benefits of bariatric surgery regarding HRV parameters.


Assuntos
Cirurgia Bariátrica , Diabetes Mellitus Tipo 2 , Humanos , Frequência Cardíaca , Diabetes Mellitus Tipo 2/cirurgia , Antropometria , Exercício Físico
8.
Nutr Metab Cardiovasc Dis ; 22(6): 495-502, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21247745

RESUMO

BACKGROUND AND AIMS: Atenolol is a beta-1 adrenergic antagonist commonly prescribed for the treatment of systemic hypertension or coronary artery disease yet its use in individuals with type 2 diabetes mellitus (T2DM) is controversial due to potentially negative side effects on insulin resistance. Non-esterified fatty acid (NEFA) metabolism is altered in T2DM especially under conditions of metabolic stress such as exercise or the postprandial state. We evaluated atenolol effects on circulating NEFA and related hormones in men with T2DM during acute cardiorespiratory exercise in both the fasting and postprandial state, including the adipokine acylation stimulating protein (ASP) which stimulates adipose tissue NEFA uptake. METHODS AND RESULTS: Ten men with T2DM underwent four 1-h exercise sessions at 60% of their maximal oxygen uptake (VO(2max)) under the following conditions: 1) fasting (F), and 2) 2 h postprandial (PP) without medication; and 3) fasting (F-Atenolol), and 4) 2 h postprandial (PP-Atenolol) after a one-week treatment with atenolol. Results were tested for the effects of atenolol via two-way ANOVA for the F vs F-Atenolol and PP vs PP-Atenolol states separately. Atenolol treatment decreased fasting and postprandial glycerol (p < 0.0001) and NEFA (p < 0.0001), postprandial epinephrine (p = 0.048), postprandial cortisol (p = 0.02), postprandial ASP (p = 0.04) and postprandial dopamine (p < 0.004). CONCLUSION: Atenolol alters fatty acid metabolism and associated metabolic hormones including ASP during exercise in men with T2DM and its effects are more apparent during conditions of stress such as the postprandial state, acute exercise and obesity.


Assuntos
Antagonistas de Receptores Adrenérgicos beta 1/farmacologia , Atenolol/farmacologia , Diabetes Mellitus Tipo 2/fisiopatologia , Exercício Físico/fisiologia , Ácidos Graxos não Esterificados/sangue , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Adulto , Complemento C3 , Estudos Cross-Over , Dopamina/sangue , Ingestão de Energia , Epinefrina/sangue , Jejum , Glicerol/sangue , Humanos , Hidrocortisona/sangue , Masculino , Pessoa de Meia-Idade , Oxigênio/metabolismo , Período Pós-Prandial
9.
Environ Res ; 111(8): 1265-70, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21962568

RESUMO

Aboriginal populations from Quebec (Canada) are exposed to higher mercury levels than southern regions since these populations consume high quantities of fish. Epidemiological evidence suggests a detrimental impact of mercury on cardiovascular risk factors such as heart rate variability (HRV) and blood pressure (BP). The objective of this study was to assess the impact of mercury exposure on BP, resting heart rate (HR) and HRV among Cree adults. Data were collected among 791 adults≥18 years old living in seven communities of the James Bay. Blood mercury and hair levels were used as biomarkers of recent and long-term exposure. BP was measured through a standardised protocol while HRV was derived from a 2-h Holter monitoring assessment. The relationship between mercury and the outcomes was studied using ANOVA and ANCOVA analysis. Geometric mean of blood mercury and hair mercury concentration was 17.0 nmol/L (95%CI: 6.1-44.0) and 2.36 nmol/g (95%CI: 2.09-2.65); respectively. After adjusting for confounders, blood mercury was associated with HRV parameters such as LF (ß=0.21, P=0.0002), HF (ß=0.15, P=0.004) and LF/HF (ß=0.06, P=0.003). Similar associations were observed with hair mercury. In contrast, no significant association was observed between blood mercury or hair mercury and BP after adjusting for confounders. In conclusion, mercury exposure seems to affect HRV among Cree adults even after considering fish nutrients (n-3 fatty acids and selenium) and other contaminants (lead and polychlorinated biphenyls) that are also present in the traditional diet of this population.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Indígenas Norte-Americanos , Mercúrio/toxicidade , Adulto , Análise de Variância , Feminino , Humanos , Masculino , Quebeque , Inquéritos e Questionários
10.
Pathol Biol (Paris) ; 58(1): 104-9, 2010 Feb.
Artigo em Francês | MEDLINE | ID: mdl-19892493

RESUMO

AIMS OF THE STUDY: A sensitive, rapid and specific diagnostic method is essential for the diagnosis of toxoplasmosis in immunocompromised hosts or in congenital infection. We report the development of a real-time PCR assay for quantitative diagnosis of toxoplasmosis with competitive internal amplification control. This PCR was applied after allogeneic stem cell transplantation to estimate the frequency of reactivation. METHODS AND PATIENTS: Primers and Taqman probe (FAM-BHQ1) were designed to amplify the 529 bp element of T. gondii. The internal amplification control was developed by cloning a fragment of Arabidopsis thaliana DNA flanked by sequences specific for T. gondii 529 bp element. A Taqman probe specific for the competitive internal control was designed and tested (YY-BHQ1). We determined the repeatability and reproducibility of the method. A prospective study was performed on adults who received an allogeneic hematopoietic stem cell transplantation. After transplantation, patients were monitored once per week during the first 100 days; they were then monitored once every 2 weeks until day 180 after transplantation (i.e., day +180). RESULTS: A total of 451 samples from 40 patients were tested. Twenty-five patients had both positive toxoplasmosis serology and an adequate chemoprophylaxis. One sample from one patient was found positive. The rate of reactivation in the population of this study is 4%. CONCLUSION: A monitoring by T. gondii PCR should be realized weekly for patients receiving an allogeneic hematopoietic stem cell transplantation, without an adequate chemoprophylaxis.


Assuntos
Transplante de Medula Óssea/efeitos adversos , DNA de Protozoário/isolamento & purificação , Terapia de Imunossupressão/efeitos adversos , Reação em Cadeia da Polimerase/métodos , Complicações Pós-Operatórias/parasitologia , Toxoplasma/isolamento & purificação , Toxoplasmose/diagnóstico , Transplante Homólogo/efeitos adversos , Adulto , Idoso , Animais , Antiprotozoários/administração & dosagem , Antiprotozoários/uso terapêutico , Arabidopsis/genética , Ligação Competitiva , Sistemas Computacionais , Sondas de DNA , DNA de Plantas/genética , DNA de Protozoário/genética , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/diagnóstico , Pré-Medicação , Estudos Prospectivos , Sequências Repetitivas de Ácido Nucleico , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Taq Polimerase , Toxoplasma/fisiologia , Toxoplasmose/etiologia , Toxoplasmose/parasitologia , Toxoplasmose/transmissão , Adulto Jovem
11.
Eur Respir J ; 34(3): 694-701, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19357147

RESUMO

The aim of the present study was to compare the efficacy of 1 yr of sibutramine-induced weight loss versus continuous positive airway pressure (CPAP) treatment on sleep-disordered breathing, cardiac autonomic function and systemic blood pressure in obese patients with obstructive sleep apnoea. Subjects with a body mass index of > or =30 kg.m(-2) without previous treatment for obstructive sleep apnoea underwent either sibutramine (n = 22) or CPAP (n = 18) treatment for 1 yr. Sibutramine induced a 5.4+/-1.4 kg decrease in body weight compared to the CPAP group, in which no changes in anthropometric variables were observed. The CPAP treatment improved all sleep and respiratory variables, whereas sibutramine-induced weight loss improved only nocturnal arterial oxygen saturation profile. Only CPAP treatment improved night-time systolic and diastolic blood pressure and 24-h and daytime ambulatory diastolic blood pressure. Sibutramine-induced weight loss had no impact on indices of heart rate variability, whereas CPAP treatment increased daytime time domain indices. CPAP treatment for 1 yr had beneficial impacts on nocturnal breathing disturbances, and improved nocturnal oxygenation, night-time systolic and diastolic blood pressure, and daytime cardiac parasympathetic modulation. Sibutramine did not improve sleep-disordered breathing, systemic blood pressure or heart rate variability. There were no adverse effects, such as increment in blood pressure or arrhythmias, associated with this treatment regimen.


Assuntos
Depressores do Apetite/uso terapêutico , Pressão Positiva Contínua nas Vias Aéreas , Ciclobutanos/uso terapêutico , Obesidade/tratamento farmacológico , Apneia Obstrutiva do Sono/terapia , Redução de Peso , Adulto , Pressão Sanguínea , Índice de Massa Corporal , Feminino , Seguimentos , Frequência Cardíaca , Humanos , Masculino , Pessoa de Meia-Idade , Obesidade/complicações , Obesidade/fisiopatologia , Polissonografia , Apneia Obstrutiva do Sono/etiologia , Apneia Obstrutiva do Sono/fisiopatologia , Resultado do Tratamento
12.
Diabet Med ; 26(6): 609-16, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19538236

RESUMO

AIMS: To examine the impact of diabetes, gender and their interaction on 30-day, 1-year and 5-year post-acute myocardial infarction (AMI) mortality in three age groups (20-64, 65-74 and > or = 75 years). METHODS: Retrospective analysis including 23 700 patients aged > or = 20 years (22% with diabetes) admitted to hospital for a first AMI in any hospital in the Province of Quebec, Canada, between April 1995 and March 1997. Administrative databases were used to identify patients and assess outcomes. RESULTS: Regarding 30-day mortality, there was non-significant interaction between diabetes and gender. Women aged < 75 years had, independently of diabetes status, at least a 38% (P < 0.05) higher mortality than their male counterparts after adjustment for socio-economic status and co-morbid conditions. Gender difference disappeared, however, after controlling for in-hospital complications. Regarding 1-year mortality (31-365 days), there was no significant gender disparity for all age groups. During the 5-year follow-up, no gender differences were seen in any age group, except for younger (< 65 years) women with diabetes, who had a 52% (P = 0.004) higher mortality than men after controlling for co-variables. This female disadvantage was demonstrated by a significant interaction between diabetes and gender in patients aged < 65 years (P = 0.009). CONCLUSIONS: The higher 30-day mortality post-AMI in younger (20-64 years) and middle-aged (65-74 years) women compared with men was not influenced by diabetes status. However, during the 5-year follow-up, the similar gender mortality observed in patients without diabetes seemed to disappear in younger patients with diabetes, which may be explained by the deleterious, long-term, post-AMI impact of diabetes in younger women.


Assuntos
Diabetes Mellitus/mortalidade , Infarto do Miocárdio/mortalidade , Adulto , Idoso , Idoso de 80 Anos ou mais , Diabetes Mellitus/epidemiologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/epidemiologia , Quebeque , Estudos Retrospectivos , Fatores Sexuais , Adulto Jovem
13.
Diabet Med ; 26(6): 589-95, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19538233

RESUMO

AIMS: A decrement in blood glucose (BG) may be observed in patients with Type 2 diabetes (T2DM) when exercise is performed after a meal, in contrast to fasting. We determined the impact of different pre-exercise meal macronutrient compositions with modulation of the glycaemic index (GI) on glucose regulation during exercise in patients with T2DM. METHODS: Using a randomized, single-blind crossover design, 10 sedentary men performed five exercise sessions, once after an overnight fast, and also after each of four test meals, consisting of a high-fat/low-carbohydrate meal, a high-GI meal, a low-GI meal, and a low-calorie meal. RESULTS: Pre-exercise BG and insulin levels were comparable for all four meals. Exercise decreased BG and insulin levels during all meal conditions (all P < 0.001) compared with the fasting state in which BG levels did not change. The magnitude of BG and insulin decrements was similar after consuming the low-calorie, the high-GI and the high-fat/low-carbohydrate meals, whereas the low-GI meal induced the lowest BG fall. Adrenaline response was higher after consumption of the high-, the low-GI and the low-caloric meals compared with the high-fat/low-carbohydrate meal and with the fasting state (P < 0.05). CONCLUSIONS: This study underlines the beneficial effect of low-GI foods and the differential impact of pre-exercise meal macronutrient composition on BG decrease. This may protect against exercise-induced hypoglycaemia, and reiterates the safety of exercising while fasting in T2DM patients.


Assuntos
Glicemia/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Epinefrina/metabolismo , Exercício Físico/fisiologia , Insulina/metabolismo , Adulto , Idoso , Estudos Cross-Over , Diabetes Mellitus Tipo 2/sangue , Carboidratos da Dieta , Jejum , Índice Glicêmico/fisiologia , Humanos , Insulina/sangue , Masculino , Pessoa de Meia-Idade , Método Simples-Cego
14.
Med Trop (Mars) ; 69(3): 295-7, 2009 Jun.
Artigo em Francês | MEDLINE | ID: mdl-19702157

RESUMO

INTRODUCTION: In spite of the high prevalence of schistosomiasis in Mali, few cases involving neurological complications have been described. The purpose of this report is to present a case associated medullary complications. CASE REPORT: A 29-year-old man was hospitalized for low back pain and difficulty in walking linked to dysesthesia. Five months earlier the patient had been trreated for schistosomiasis contracted during a trip to Dogon region of Mali. Based on radiological and laboratory findings and previous clinical history, the difinitive diagnosis was schistosomal myelopathy. DISCUSSION/CONCLUSION: Neuroschistosomiasis is a rare but serious complication of the schistosomiasis that can only be made after complete parasite identification and careful differential diagnosis. Treatment with antiparasitic agents in association with corticosteroids is mandatory but must only be initiated in state stage of the parasitic infection, i.e., after maturation of larvae into adults.


Assuntos
Neuroesquistossomose/diagnóstico , Esquistossomose mansoni/diagnóstico , Ciática/etiologia , Adulto , Anti-Helmínticos/uso terapêutico , Diagnóstico Diferencial , Glucocorticoides/uso terapêutico , Humanos , Masculino , Mali , Metilprednisolona/uso terapêutico , Neuroesquistossomose/complicações , Neuroesquistossomose/tratamento farmacológico , Praziquantel/uso terapêutico , Esquistossomose mansoni/complicações , Esquistossomose mansoni/tratamento farmacológico , Ciática/tratamento farmacológico
15.
Diabetes Metab ; 34(2): 169-76, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18396087

RESUMO

AIMS: To assess whether elderly patients with type 2 diabetes use a comprehensive cardioprotective regimen (CCR) of antihypertensive, lipid-lowering and antiplatelet drugs in the year following oral antidiabetic drug initiation and, if so, to identify the determinants of such use. METHODS: Using the Quebec Diabetes Surveillance System administrative database, we carried out an inception cohort study of individuals aged 66 years and over who began oral antidiabetic therapy between 1998 and 2002. Those individuals with at least one claim in the year after starting antidiabetic treatment for an antihypertensive, a lipid-lowering and an antiplatelet drugs were deemed to be using a CCR. A multivariate logistic regression model was built to identify the characteristics associated with CCR use. RESULTS: Of the 48,505 individuals included in the study, 9912 (20.4%) used a CCR during the year following the first antidiabetic claim. Those more likely to use a CCR were men (odds ratio [OR]: 1.2; 99% confidence intervals [CI]: 1.1-1.3), those who had used an antihypertensive (1.6; 1.4-1.7), lipid-lowering (7.4; 6.8-8.0) or antiplatelet (7.3; 6.7-7.9) drug in the year before the first antidiabetic claim and those with a preexisting diagnosis of cardiovascular disease (1.9; 1.8-2.1). The odds of using a CCR increased every year. CONCLUSIONS: CCR use by the elderly with type 2 diabetes in the year following antidiabetic initiation is low, and prior use of individual cardioprotective drugs is a strong predictor of its use. These findings suggest that the treatment of important modifiable risk factors for cardiovascular disease is suboptimal.


Assuntos
Cardiotônicos/uso terapêutico , Diabetes Mellitus Tipo 2/fisiopatologia , Tratamento Farmacológico/estatística & dados numéricos , Hipoglicemiantes/uso terapêutico , Administração Oral , Idoso , Anti-Hipertensivos/uso terapêutico , Bases de Dados Factuais , Prescrições de Medicamentos , Feminino , Humanos , Hipoglicemiantes/administração & dosagem , Hipolipemiantes/uso terapêutico , Masculino , Pessoa de Meia-Idade , Razão de Chances , Inibidores da Agregação Plaquetária/uso terapêutico , Quebeque
16.
Rev Mal Respir ; 25(6): 663-73, 2008 Jun.
Artigo em Francês | MEDLINE | ID: mdl-18772824

RESUMO

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is characterized mainly by airway obstruction due to chronic bronchitis and/or emphysema. In addition, COPD is frequently associated with other health problems with serious systemic manifestations. In particular, COPD patients are at increased risk of cardiovascular disease. BACKGROUND: Current knowledge about cardiovascular disease in patients with COPD mainly concerns the high prevalence of cardiac arrhythmias in this population. Systemic hypertension, cardiovascular disease, heart failure and cerebro-vascular disease are also frequently encountered. This review discusses the cardiovascular manifestations associated with COPD, excluding right heart failure due to pulmonary hypertension. VIEWPOINTS AND CONCLUSION: Non pulmonary health problems in patients with COPD, such as cardiovascular disease, are arousing increasing interest in the medical community. More studies are needed to increase our knowledge of cardiovascular disease in COPD and allow better medical management of patients.


Assuntos
Doenças Cardiovasculares/epidemiologia , Doença Pulmonar Obstrutiva Crônica/complicações , Desequilíbrio Ácido-Base , Idoso , Antiarrítmicos/uso terapêutico , Arritmias Cardíacas/diagnóstico , Arritmias Cardíacas/tratamento farmacológico , Arritmias Cardíacas/epidemiologia , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/tratamento farmacológico , Doenças Cardiovasculares/etiologia , Transtornos Cerebrovasculares/epidemiologia , Doença das Coronárias/tratamento farmacológico , Doença das Coronárias/epidemiologia , Doença das Coronárias/etiologia , Eletrocardiografia , Feminino , Insuficiência Cardíaca/epidemiologia , Humanos , Hipertensão/epidemiologia , Hipertensão/etiologia , Hipóxia/complicações , Incidência , Estilo de Vida , Masculino , Pessoa de Meia-Idade , Prevalência , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Cardiopulmonar/etiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Testes de Função Respiratória , Fatores de Risco , Fumar/efeitos adversos
17.
Int J Stroke ; 13(9): 949-984, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30021503

RESUMO

The 2018 update of the Canadian Stroke Best Practice Recommendations for Acute Stroke Management, 6th edition, is a comprehensive summary of current evidence-based recommendations, appropriate for use by healthcare providers and system planners caring for persons with very recent symptoms of acute stroke or transient ischemic attack. The recommendations are intended for use by a interdisciplinary team of clinicians across a wide range of settings and highlight key elements involved in prehospital and Emergency Department care, acute treatments for ischemic stroke, and acute inpatient care. The most notable changes included in this 6th edition are the renaming of the module and its integration of the formerly separate modules on prehospital and emergency care and acute inpatient stroke care. The new module, Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care is now a single, comprehensive module addressing the most important aspects of acute stroke care delivery. Other notable changes include the removal of two sections related to the emergency management of intracerebral hemorrhage and subarachnoid hemorrhage. These topics are covered in a new, dedicated module, to be released later this year. The most significant recommendation updates are for neuroimaging; the extension of the time window for endovascular thrombectomy treatment out to 24 h; considerations for treating a highly selected group of people with stroke of unknown time of onset; and recommendations for dual antiplatelet therapy for a limited duration after acute minor ischemic stroke and transient ischemic attack. This module also emphasizes the need for increased public and healthcare provider's recognition of the signs of stroke and immediate actions to take; the important expanding role of paramedics and all emergency medical services personnel; arriving at a stroke-enabled Emergency Department without delay; and launching local healthcare institution code stroke protocols. Revisions have also been made to the recommendations for the triage and assessment of risk of recurrent stroke after transient ischemic attack/minor stroke and suggested urgency levels for investigations and initiation of management strategies. The goal of this updated guideline is to optimize stroke care across Canada, by reducing practice variations and reducing the gap between current knowledge and clinical practice.


Assuntos
Serviços Médicos de Emergência/legislação & jurisprudência , Serviço Hospitalar de Emergência/legislação & jurisprudência , Ataque Isquêmico Transitório/terapia , Acidente Vascular Cerebral/terapia , Canadá , Cuidados Críticos/legislação & jurisprudência , Atenção à Saúde/legislação & jurisprudência , Hospitalização/legislação & jurisprudência , Humanos , Pacientes Internados , Acidente Vascular Cerebral/diagnóstico
18.
Acta Diabetol ; 44(3): 114-20, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17721749

RESUMO

The effects of metabolic states of fasting and post-absorption on plasma concentrations of free carnitine (FC), acylcarnitine (AC) and total carnitine (TC) were compared during submaximal exercise in subjects with type 2 diabetes mellitus. Ten sedentary men (54+/-5 years) treated with oral hypoglycaemic agents were tested on two separate occasions: following an overnight fast and 2 h after a 395-kcal standardised breakfast. Exercise was performed at 60% of [Formula: see text]O(2peak) on a cycle ergometer for 60 min. Blood samples were drawn at rest for baseline values and following 60 min of exercise and 30 min of recovery. Our results show that: (1) baseline levels of TC, FC and AC were similar in fasted and postprandial groups, (2) TC and AC levels were increased during exercise in the fasted group only, (3) FC levels were decreased during exercise in both fasted and postprandial state and (4) the AC/FC ratio increased during exercise in the fasted group. Our results indicate that the metabolic state of the diabetic patient is associated with a different plasma carnitine status. These patterns may reflect differences in energy metabolism associated with fasting and postprandial hyperglycaemia.


Assuntos
Carnitina/sangue , Diabetes Mellitus Tipo 2/sangue , Exercício Físico/fisiologia , Jejum/fisiologia , Consumo de Oxigênio , Período Pós-Prandial , Aerobiose , Índice de Massa Corporal , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/fisiopatologia , Ácidos Graxos não Esterificados/sangue , Hemoglobinas Glicadas/análise , Humanos , Hipoglicemiantes/uso terapêutico , Insulina/sangue , Masculino
19.
Clin Microbiol Infect ; 23(12): 994-999, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28487164

RESUMO

OBJECTIVES: Fungi belonging to the Metarhizium anisopliae complex comprise ubiquitous arthropod pathogenic moulds used as mycopesticides. Rare cases of human infections due to M. anisopliae have been reported. We hypothesize misidentifications of fungal strains implicated in these cases or used in mycopesticides. METHODS: A review of the literature was conducted to identify previously published cases. We collected some of these previous described strains and reported new cases, and a French mycopesticide containing M. anisopliae. All identifications were performed based on elongation factor-1α gene sequencing. RESULTS: We report eight new cases of Metarhizium infection in humans (three from France and five from Australia). The strains isolated from these cases, and three others from already published cases and reported as M. anisopliae, were molecularly identified based on elongation factor-1α (Ef1-α) gene sequencing as follows: Metarhizium robertsii (six), Metarhizium guizhouense (three), Metarhizium brunneum (one) and Metarhizium pingshaense (one). CONCLUSIONS: In this study, we report new human cases of Metarhizium infections, and, based on Ef-1α gene sequencing, we demonstrate the misidentification of species in case reports. We also correct the species identification of a strain reported as M. anisopliae used in a commercially available mycopesticide. According to our results, none of the strains from the human infection reports reviewed belongs to the species M. anisopliae.


Assuntos
Metarhizium , Micoses/microbiologia , Adolescente , Adulto , Idoso , Antifúngicos/uso terapêutico , Criança , Pré-Escolar , Erros de Diagnóstico , Feminino , Genes Fúngicos/genética , Humanos , Masculino , Metarhizium/genética , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Micoses/diagnóstico , Micoses/tratamento farmacológico , Filogenia , Estudos Retrospectivos , Análise de Sequência de DNA
20.
Chir Main ; 25(2): 63-8, 2006 Jun.
Artigo em Francês | MEDLINE | ID: mdl-16841766

RESUMO

We report a series with the adipofascio cutaneous flap of the dorsal aspect of long fingers used with an anterograde or retrograde pedicle. Thirty flaps were performed in 29 patients with a mean age of 43 years, 16 cases in emergency and 13 cases secondary for the treatement of traumatic sequelae. The adipofascial pedicle was retrograde for 22 flaps and anterograde for 8 flaps. The donor site was adjacent of the cutaneous defect in 21 cases or at a distance in 9 cases. Transcient veinous congestion was observed in 2 cases. No necrosis was reported. A second surgery of plasty was performed in 1 case for a cutaneous bulk. The quality of the cutaneous coverage gave any functional discomfort and was evaluated very satisfying. These flaps have an important adaptabily of utilization depending on the localisation and the size of the cutaneous defect as well as the quality of its surrounding skin. The homodigital feature of these flaps avoids the disadvantages of the dorsal hand flaps or the heterodigital flaps. Due to their anastomotic vascularisation, these flaps are reliable and therefore can be recommended for the treatment of dorsal cutaneous defects of long fingers less than 2.5 cm.


Assuntos
Traumatismos dos Dedos/cirurgia , Retalhos Cirúrgicos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Feminino , Sobrevivência de Enxerto , Humanos , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA